Pipes Feed Preview: ClinicalTrials.gov: COVID-19 | Last update posted in the last 14 days

1. Small Airway Disease And Bronchial Hyperreactivity In Patients With Post Acute Covid-19 Syndrome

   2024-04-18 04:00:00 UTC

   Conditions: COVID-19
   Sponsors: Mansoura University
   Completed

2. Effect of Virtual Reality in Patients With Long Covid-19

   2024-04-18 04:00:00 UTC

   Conditions: COVID-19
   Interventions: Other: Classical Treatment; Other: Virtual Reality Combined with Classical Treatment; Other: Virtual Reality; Other: Control Group
   Sponsors: Istinye University
   Not yet recruiting

3. A Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a COVID-19 mRNA Vaccine in Adults Aged 50 Years and Above

   2024-04-18 04:00:00 UTC

   Conditions: Respiratory Syncytial Virus Infections
   Interventions: Biological: RSVPreF3 OA investigational vaccine; Biological: COVID-19 mRNA vaccine
   Sponsors: GlaxoSmithKline
   Not yet recruiting

4. Air Purifiers in Classrooms for Infection Control - a Pilot Study

   2024-04-18 04:00:00 UTC

   Conditions: Feasibility; Acceptability
   Interventions: Device: Ceiling-Mounted Air Purifiers; Device: Portable Air Purifiers; Device: Portable or Ceiling Mounted Air Purifiers
   Sponsors: Norwegian Institute of Public Health; SINTEF Health Research
   Active, not recruiting

5. Stress in Pregnancy During the Covid19 Pandemic and Impact on the Newborn Neurodevelopment

   2024-04-12 04:00:00 UTC

   Conditions: Covid19 and Pregnancy
   Interventions: Other: Severity of infection, time of infection.; Other: Mental health assessment; Other: biological
   Sponsors: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
   Active, not recruiting

6. Effects of Unsupervised Inspiratory Muscle Training on Ventilation Variability in Post-covid-19 Patients.

   2024-04-12 04:00:00 UTC

   Conditions: COVID-19
   Interventions: Device: Experimental Group
   Sponsors: Universidade Federal do Rio Grande do Norte
   Recruiting

7. Clinical Evaluation of the NeuMoDx SARS-CoV-2 Assay (COVID-19)

   2024-04-11 04:00:00 UTC

   Conditions: SARS-CoV-2 Acute Respiratory Disease
   Interventions: Diagnostic Test: NeuMoDx SARS-CoV-2 Assay
   Sponsors: QIAGEN Gaithersburg, Inc
   Recruiting

8. A Phase IV Vaccine Study Under the National Cohort Study of Effectiveness and Safety of SARS-CoV-2 (COVID-19) Vaccines.

   2024-04-11 04:00:00 UTC

   Conditions: SARS CoV 2 Infection
   Interventions: Biological: Johnson & Johnson
   Sponsors: Jens D Lundgren, MD; Ministry of the Interior and Health, Denmark
   Completed

9. Assessement of Microcirculation With NIRS Predicts Sepsis Development in Patients With Severe Covid-19 Pneumonia

   2024-04-11 04:00:00 UTC

   Conditions: Sepsis
   Sponsors: General and Teaching Hospital Celje
   Completed

10. COVID Quick Start - Test and Treat in Africa

    2024-04-11 04:00:00 UTC

    Conditions: COVID-19
    Sponsors: Duke University; Duke Clinical Research Institute; Clinton Health Access Initiative, Nigeria
    Active, not recruiting

11. Detoxification From the Lipid Tract

    2024-04-10 04:00:00 UTC

    Conditions: COVID-19 Vaccine Adverse Reaction
    Interventions: Device: electroencephalogram biofeedback; Device: electrical brain stimulation; Device: ultra-low frequency transcranial magnetic stimulation; Drug: Sertraline Hydrochloride; Drug: Clonazepam; Drug: Alprazolam; Drug: Metoprolol; Drug: Olanzapine; Drug: Pravastatin Sodium 20 MG; Drug: Sacubitril Valsartan Sodium Hydrate
    Sponsors: Pachankis, Yang I., M.D.; First Affiliated Hospital of Chongqing Medical University
    Completed

12. Collaborative Open Research Initiative Study (CORIS-1)

    2024-04-10 04:00:00 UTC

    Conditions: Patient Engagement; COVID-19; Preventable Disease, Vaccine; Burnout, Professional; Emerging Infectious Disease; Artificial Intelligence; Climate Change; Online Education; Mental Health Issue; Substance Use Disorders
    Interventions: Other: No intervention. This is an observational study
    Sponsors: Chisquares Incorporated
    Not yet recruiting

13. A Study of the Efficacy of Troxerutin in Preventing Thrombotic Events in COVID-19 Patients

    2024-04-09 04:00:00 UTC

    Conditions: COVID 19 Associated Coagulopathy
    Interventions: Drug: Troxerutin; Drug: Placebo; Drug: placebo + low molecular weight heparin; Drug: troxerutin + low molecular weight heparin
    Sponsors: Westlake University; Shaoxing Central Hospital
    Recruiting

14. External Validation of Simplified 4C Mortality Score by Deleting CRP

    2024-04-09 04:00:00 UTC

    Conditions: COVID-19 Pandemic
    Sponsors: University of Monastir
    Completed

15. A Cross-sectional Study of Ocular Manifestations During the Covid-19 Pandemic in Hubei Province

    2024-04-09 04:00:00 UTC

    Conditions: COVID-19; Ocular Surface Disease
    Interventions: Other: NOT
    Sponsors: Zhongnan Hospital; Qichun People's Hospital
    Active, not recruiting

16. A Study of an Investigational mRNA-1273.815 COVID-19 Vaccine in Previously Vaccinated Adults

    2024-04-09 04:00:00 UTC

    Conditions: SARS-CoV-2
    Interventions: Biological: Investigational mRNA-1273.815; Biological: Licensed Spikevax Vaccine
    Sponsors: ModernaTX, Inc.
    Not yet recruiting

17. Covid-19 and Influenza Oral Vaccine Study

    2024-04-09 04:00:00 UTC

    Conditions: covid19 Infection; Influenza, Human
    Interventions: Biological: Covid-19 vaccine; Biological: Influenza vaccine
    Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute Ltd
    Not yet recruiting

18. The Use of Isatidis Root and Forsythia Oral Liquid for the Treatment of Mild Cases of COVID-19: A Trial Clinical Study

    2024-04-09 04:00:00 UTC

    Conditions: Treatment of Mild Cases of COVID-19
    Interventions: Drug: Langenlianqiao; Drug: LianhuaQingWen; Other: placebo control group
    Sponsors: Central South University
    Completed

19. Covid-19 Pandemic and Pediatric Dentistry

    2024-04-08 04:00:00 UTC

    Conditions: COVID-19 Pandemic
    Interventions: Other: Survey
    Sponsors: Abant Izzet Baysal University
    Completed

20. Investigating Long-term Health Effects and Complications in COVID-19 Recoveries

    2024-04-05 04:00:00 UTC

    Conditions: COVID-19 Patients
    Interventions: Behavioral: respiratory rehabilitation
    Sponsors: Zhaohui Tong
    Recruiting

21. The Real-world Clinical Study of Azvudine Tablets in the Treatment of COVID-19

    2024-04-05 04:00:00 UTC

    Conditions: COVID-19; Azvudine
    Interventions: Drug: Azvudine; Drug: Paxlovid
    Sponsors: The First Affiliated Hospital of Zhengzhou University; Henan Provincial Chest Hospital; The Affiliated Infectious Disease Hospital of Zhengzhou University; The Fifth People's Hospital of Anyang; Shangqiu Municipal Hospital; Nanyang Central Hospital; Luoyang Central Hospital; Guangshan County People's Hospital; Fengqiu County People's Hospital
    Completed

22. Multiplex PCR for Severe Respiratory Infections During the COVID-19 Pandemic

    2024-04-05 04:00:00 UTC

    Conditions: Viral Pneumonia
    Interventions: Other: other: Observational
    Sponsors: Central Hospital, Nancy, France
    Not yet recruiting

23. Fascial Tissue Response To Manual Therapy: Implications In Long Covid Rehabilitation

    2024-04-04 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Other: Guidebook; Other: Guidebook and Myofascial Reorganization® (RMF).
    Sponsors: University of the State of Santa Catarina; Larissa Sinhorim
    Recruiting

24. Effect of Probiotic Strain Lactobacillus Paracasei PS23 on Brain Fog in People With Long COVID

    2024-04-04 04:00:00 UTC

    Conditions: Long COVID; Brain Fog; Cognitive Change
    Interventions: Dietary Supplement: Lactobacillus paracasei PS23; Dietary Supplement: microcrystalline cellulose
    Sponsors: Taipei Veterans General Hospital, Taiwan
    Not yet recruiting

25. Optimal Timing for Tracheostomy in Invasively Mechanically Ventilated COVID-19 Patients

    2024-04-03 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Procedure: Tracheostomy
    Sponsors: Uppsala University; Healthcare Region Dalarna
    Completed

26. Diaphragmatic Breathing Exercises for Post-COVID-19 Diaphragmatic Dysfunction (DD)

    2024-03-26 04:00:00 UTC

    Conditions: Post-Acute Sequelae of COVID-19
    Interventions: Other: Usual care of traditional treatment; Other: Specific DB program/Diaphragmatic manipulation program
    Sponsors: University of Minnesota
    Recruiting

27. RECOVER-AUTONOMIC Platform Protocol

    2024-03-12 04:00:00 UTC

    Conditions: Long COVID; Long Covid19; Long Covid-19
    Interventions: Drug: IVIG + Coordinated Care; Drug: IVIG Placebo + Coordinated Care; Drug: Ivabradine + Coordinated Care; Drug: Ivabradine Placebo + Coordinated Care; Drug: IVIG + Usual Care; Drug: IVIG Placebo + Usual Care; Drug: Ivabradine + Usual Care; Drug: Ivabradine Placebo + Usual Care
    Sponsors: Kanecia Obie Zimmerman
    Enrolling by invitation

28. RECOVER-AUTONOMIC: Platform Protocol, Appendix B (Ivabradine)

    2024-03-12 04:00:00 UTC

    Conditions: Long COVID; Long Covid19; Long Covid-19
    Interventions: Drug: Ivabradine; Drug: Ivabradine Placebo; Behavioral: Coordinated Care; Behavioral: Usual Care
    Sponsors: Kanecia Obie Zimmerman
    Enrolling by invitation

29. RECOVER-AUTONOMIC: Platform Protocol, Appendix A (IVIG)

    2024-03-12 04:00:00 UTC

    Conditions: Long COVID; Long Coronavirus Disease 2019 (Covid19); Long Covid-19
    Interventions: Drug: IVIG (intravenous immunoglobulin); Drug: IVIG Placebo; Behavioral: Coordinated Care; Behavioral: Usual Care
    Sponsors: Kanecia Obie Zimmerman
    Enrolling by invitation

30. An E-health Psychoeducation for People With Bipolar Disorders

    2024-03-06 05:00:00 UTC

    Conditions: Bipolar Disorder; Psychoeducation; COVID-19 Pandemic
    Interventions: Other: e-health psychoeducation
    Sponsors: University of Cagliari; Alessandra Perra
    Completed

31. A Study to Learn About the Use of Paxlovid in Patients With COVID-19 in the Kingdom of Bahrain.

    2024-03-04 05:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: nirmatrelvir, ritonavir; Other: Controls
    Sponsors: Pfizer
    Active, not recruiting

32. Study to Evaluate the Safety & Immunogenicity of IMNN-101 Administered in Healthy Adults Previously Vaccinated Against SARS-CoV-2

    2024-02-28 05:00:00 UTC

    Conditions: SARS CoV 2 Infection
    Interventions: Biological: IMNN-101
    Sponsors: Imunon
    Not yet recruiting

33. Acute Cardiovascular Responses to a Single Exercise Session in Patients With Post-COVID-19 Syndrome

    2024-02-08 05:00:00 UTC

    Conditions: Post-Acute COVID-19 Syndrome
    Interventions: Behavioral: Exercise session; Behavioral: Control session
    Sponsors: University of Nove de Julho
    Recruiting

34. Long COVID-19 [11C]CPPC Study

    2024-01-25 05:00:00 UTC

    Conditions: COVID Long-Haul
    Interventions: Drug: [11C]CPPC Injection; Drug: [11C]CPPC Injection
    Sponsors: Johns Hopkins University; Radiological Society of North America
    Recruiting

35. Diet and Fasting for Long COVID

    2024-01-19 05:00:00 UTC

    Conditions: Long Covid19; Long COVID
    Interventions: Other: Low sugar diet and 10-12 hour eating window; Other: Low sugar diet, 8 hour eating window and fasting
    Sponsors: Pacific Northwest University of Health Sciences
    Recruiting

36. Neural and Cognitive Consequences of COVID-19 Survival

    2024-01-17 05:00:00 UTC

    Conditions: COVID Long-Haul; COVID-19; COVID-19 Pandemic; Brain Fog; Memory Deficits; Concentration Ability Impaired; Fatigue
    Interventions: Other: cross-sectional MRI and EEG assessments (NO INTERVENTION)
    Sponsors: San Francisco Veterans Affairs Medical Center
    Recruiting

37. A Study to Evaluate the Safety, Tolerability, and Immunogenicity of a Combined Modified RNA Vaccine Candidate Against COVID-19 and Influenza.

    2023-12-21 05:00:00 UTC

    Conditions: Influenza; COVID-19
    Interventions: Biological: Influenza and COVID-19 Combination A; Biological: Licensed influenza vaccine; Biological: COVID-19 Vaccine; Biological: Influenza and COVID-19 Combination B; Biological: Placebo
    Sponsors: BioNTech SE; Pfizer
    Recruiting

38. Exercise Training Using an App on Physical Cardiovascular Function Individuals With Post-covid-19 Syndrome

    2023-12-13 05:00:00 UTC

    Conditions: Post-Acute COVID-19 Syndrome
    Interventions: Behavioral: Exercise; Behavioral: Control
    Sponsors: University of Nove de Julho
    Recruiting

39. Ensitrelvir for Viral Persistence and Inflammation in People Experiencing Long COVID

    2023-12-08 05:00:00 UTC

    Conditions: Long COVID; Post Acute Sequelae of COVID-19; Post-Acute COVID-19
    Interventions: Drug: Ensitrelvir; Other: Placebo
    Sponsors: Timothy Henrich; Shionogi Inc.
    Enrolling by invitation

40. Safety Study of SLV213 for the Treatment of COVID-19.

    2023-11-24 05:00:00 UTC

    Conditions: COVID-19
    Interventions: Other: Placebo for SLV213; Drug: SLV213
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

41. Collection of Additional Biological Samples From Potentially COVID-19 Patients for Monitoring of Biological Parameters Carried Out as Part of the Routine

    2023-11-22 05:00:00 UTC

    Conditions: SARS CoV 2 Infection
    Interventions: Diagnostic Test: RIPH2
    Sponsors: CerbaXpert
    Not yet recruiting

42. Special Investigation for Booster Dose of Comirnaty in Children Ages 6 Months Though 4 Years

    2023-11-14 05:00:00 UTC

    Conditions: SARS-CoV-2; COVID-19
    Interventions: Biological: COMIRNATY intramuscular injection
    Sponsors: Pfizer
    Active, not recruiting

43. Building Engagement Using Financial Incentives Trial - Colorectal Cancer Screening

    2023-11-09 05:00:00 UTC

    Conditions: Health Behavior; Colorectal Cancer; Influenza; COVID-19; Vaccine Hesitancy; Vaccine-Preventable Diseases; Healthcare Patient Acceptance
    Interventions: Behavioral: Financial incentive for colorectal cancer screening; Behavioral: Financial incentive for flu shot; Behavioral: Financial incentive for COVID-19 shot
    Sponsors: Tulane University; National Heart, Lung, and Blood Institute (NHLBI)
    Completed

44. Brief Digital Intervention to Increase COVID-19 Vaccination Among Individuals With Anxiety or Depression

    2023-11-07 05:00:00 UTC

    Conditions: Misinformation; Vaccine Hesitancy; Anxiety; Depression; COVID-19
    Interventions: Behavioral: Attitudinal inoculation; Behavioral: Cognitive-behavioral therapy-informed intervention; Behavioral: Conventional public health messaging
    Sponsors: City University of New York, School of Public Health; University of North Carolina, Chapel Hill
    Enrolling by invitation

45. Pilot Randomized Study of RD-X19 Tx Device in Subjects With PCC (Long Covid) in the Outpatient Setting

    2023-11-02 04:00:00 UTC

    Conditions: Post COVID-19 Condition (PCC)
    Interventions: Device: RDX-19
    Sponsors: EmitBio Inc.; NAMSA
    Active, not recruiting

46. Effects of an EMDR Intervention on Traumatic and Obsessive Symptoms

    2023-11-01 04:00:00 UTC

    Conditions: Adult ALL; Post-traumatic Stress Disorder; Obsessive-Compulsive Disorder; Disgust; Guilt; Shame
    Interventions: Behavioral: EMDR
    Sponsors: University of Pisa
    Completed

47. Cognitive Rehabilitation Therapy for COVID-19

    2023-10-17 04:00:00 UTC

    Conditions: Post-Acute COVID-19 Syndrome
    Interventions: Behavioral: Compensatory Cognitive Training for COVID-19; Behavioral: Holistic Cognitive Education
    Sponsors: VA Office of Research and Development
    Not yet recruiting

48. Examining the Function of Cs4 on Post-COVID-19 Disorders

    2023-09-26 04:00:00 UTC

    Conditions: Long COVID
    Interventions: Other: Chinese medicine nutritional supplement Cs4
    Sponsors: The University of Hong Kong
    Recruiting

49. Stellate Ganglion Block With Lidocaine for the Treatment of COVID-19-Induced Parosmia

    2023-09-26 04:00:00 UTC

    Conditions: Parosmia
    Interventions: Procedure: Stellate Ganglion Block; Other: Placebo
    Sponsors: Lawson Health Research Institute
    Recruiting

50. A Study of Post COVID-19 Mechanisms for Chronic Lung Sequelae

    2023-08-23 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Procedure: Bronchoscopies and Bronchoalveolar Lavages (BALs); Diagnostic Test: Chest Tomography (CT); Diagnostic Test: Electrocardiogram (ECG); Diagnostic Test: Pulmonary function tests (PFTs); Diagnostic Test: 6 minute walk test (6MWT)
    Sponsors: Mayo Clinic
    Recruiting

51. Study of LAU-7b for the Treatment of Long COVID in Adults

    2023-08-21 04:00:00 UTC

    Conditions: Long COVID
    Interventions: Drug: LAU-7b for 3 cycles; Drug: LAU-7b for 1 cycle, then placebo; Other: Placebo for 3 cycles
    Sponsors: Laurent Pharmaceuticals Inc.
    Recruiting

52. PROTECT-APT 1: Early Treatment and Post-Exposure Prophylaxis of COVID-19

    2023-07-20 04:00:00 UTC

    Conditions: SARS-CoV-2
    Interventions: Drug: Upamostat; Drug: Placebo (PO)
    Sponsors: Henry M. Jackson Foundation for the Advancement of Military Medicine; Joint Program Executive Office Chemical, Biological, Radiological, and Nuclear Defense Enabling Biotechnologies; RedHill Biopharma Limited; FHI Clinical, Inc.
    Recruiting

53. Treatment of Long CoronaVirus Disease (COVID) (TLC) Feasibility Trial

    2023-07-14 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: Cetirizine; Drug: Famotidine; Drug: Cetirizine Placebo; Drug: Famotidine Placebo
    Sponsors: Emory University; CURE Drug Repurposing Collaboratory (CDRC)
    Recruiting

54. RADx-UP CDCC Rapid Research Pilot Program "Culturally-relevant Community Connections (C3) to Increase COVID-19 Testing

    2023-06-26 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Diagnostic Test: Covid-19 Antibody Test; Other: Short Clip videos
    Sponsors: Duke University; National Institutes of Health (NIH)
    Recruiting

55. To Investigate Efficacy, Pharmacodynamics, and Safety of BC 007 in Participants With Long COVID

    2023-06-20 04:00:00 UTC

    Conditions: Long Covid
    Interventions: Drug: BC 007 or matching placebo
    Sponsors: Berlin Cures GmbH
    Active, not recruiting

56. Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19

    2023-06-06 04:00:00 UTC

    Conditions: Pulmonary Fibrosis; COVID-19 Pneumonia
    Interventions: Drug: Bailing capsule
    Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University
    Recruiting

57. Smell Training and Trigeminal Nerve Stimulation for COVID-related Smell Loss

    2023-05-11 04:00:00 UTC

    Conditions: Smell Dysfunction; Olfactory Disorder; Long COVID
    Interventions: Device: Trigeminal Nerve Stimulation (TNS); Other: Active Smell Training (ST); Other: Placebo Smell Training (PBO)
    Sponsors: Medical University of South Carolina; National Institutes of Health (NIH); National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting

58. Disease-related Fatigue Monitoring Based on Body Signals Measured on the Skin

    2023-05-10 04:00:00 UTC

    Conditions: Post-COVID-19 Related Fatigue
    Interventions: Procedure: Respiratory training
    Sponsors: Simon Annaheim; Kliniken Valens, Klinik Gais
    Recruiting

59. The LUSZ COVID-19 Severity Index: A Prognostic and Predictive Score of Mortality for Hospitalized Patients With Covid-19

    2023-05-08 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Other: LUSZ P
    Sponsors: Lebanese University; Hospital Saydet Zgharta University Medical Center
    Recruiting

60. Strategies and Treatments for Respiratory Infections &Amp; Viral Emergencies (STRIVE): Immune Modulation Strategy Trial

    2023-04-21 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: abatacept infusion; Drug: Placebo group
    Sponsors: University of Minnesota
    Recruiting

61. Long Term Impact of COVID-19

    2023-04-14 04:00:00 UTC

    Conditions: Long COVID-19; Post-COVID-19 Syndrome; COVID-19
    Interventions: Other: Observational patient reported outcomes
    Sponsors: Medisch Spectrum Twente; University of Twente; Ziekenhuisgroep Twente
    Active, not recruiting

62. Effect of a Health Pathway for People With Persistent Symptoms Covid-19

    2023-03-28 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Other: usual care and follow-up by a nurse; Other: Personalized Multifactorial Intervention (IMP)
    Sponsors: Centre Hospitalier Universitaire de Saint Etienne
    Recruiting

63. Basel Long COVID-19 Cohort Study and Digital Long COVID Substudy

    2023-03-23 04:00:00 UTC

    Conditions: Post COVID-19 Condition (PCC)
    Interventions: Other: Digital intervention (DiLCoS); Other: Data collection
    Sponsors: University Hospital, Basel, Switzerland; State Secretariat for Education Research and Innovation, Switzerland; European Union's Horizon Europe research and innovation programme
    Recruiting

64. Clinical Study for the Efficacy and Safety of Ropeginterferon Alfa-2b in Moderate COVID19.

    2023-03-15 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: P1101 (Ropeginterferon alfa-2b); Procedure: SOC
    Sponsors: National Taiwan University Hospital
    Completed

65. Procedural Motor Memory in Long COVID-19

    2023-02-28 05:00:00 UTC

    Conditions: Infectious Metabolic Encephalopathy; Ischemic Stroke; Seizure; Viral Encephalitis, Small and Large Vessel
    Interventions: Behavioral: keypresses
    Sponsors: National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting

66. The Long COVID-19 Wearable Device Study

    2023-02-23 05:00:00 UTC

    Conditions: Long COVID; Postural Orthostatic Tachycardia Syndrome; Dysautonomia; Myalgic Encephalomyelitis; Chronic Fatigue Syndrome; Long Covid19
    Interventions: Device: Wearable device
    Sponsors: Scripps Translational Science Institute
    Recruiting

67. Evaluation of Corfluvec Vaccine for the Prevention of COVID-19 in Healthy Volunteers

    2023-01-25 05:00:00 UTC

    Conditions: COVID-19
    Interventions: Biological: Corfluvec component 1 low dose; Biological: Corfluvec component 2 low dose; Biological: Corfluvec component 1 high dose; Biological: Corfluvec component 2 high dose; Biological: Corfluvec low dose; Biological: Corfluvec high dose; Biological: Placebo
    Sponsors: Tatyana Zubkova; MDP-CRO, LLC; St. Petersburg State Pavlov Medical University
    Completed

68. Mechanism and Immune Function Analysis of SARS-CoV-2 Infection in Hematologic Tumors

    2023-01-13 05:00:00 UTC

    Conditions: SARS-CoV-2 Infection; Hematologic Malignancy
    Interventions: Other: None intervention
    Sponsors: Peking University First Hospital
    Active, not recruiting

69. Understanding COVID-19 Vaccine Immunity in Tissue and Blood

    2023-01-12 05:00:00 UTC

    Conditions: COVID-19 (Coronavirus Disease 2019)
    Interventions: Other: No intervention
    Sponsors: Stanford University; National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

70. Qigong for Post Acute Sequelae of COVID-19 Infection

    2023-01-09 05:00:00 UTC

    Conditions: Long COVID
    Interventions: Behavioral: External Qigong
    Sponsors: University of California, Davis
    Active, not recruiting

71. Study to Determine the Response to COVID-19 Vaccination and Prevalence of COVID-19 in Subjects With Chronic Liver Disease

    2023-01-03 05:00:00 UTC

    Conditions: Chronic or Recovered Hepatitis B; Chronic or Recovered Hepatitis C; Chronic or Recovered Hepatitis D; NAFLD; NASH
    Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
    Active, not recruiting

72. ImmunoCARE: Rapid, Accurate COVID Testing to Reduce Hospitalization of Immunocompromised Individuals

    2022-12-19 05:00:00 UTC

    Conditions: Immunodeficiency; Immunosuppression; HIV Infections; Graft Versus Host Disease; Leukemia; Lymphoma; Cancer; Multiple Myeloma; Transplant; Age-Related Immunodeficiency
    Interventions: Other: Access to Cue Health COVID-19 Remote testing and treatment for COVID-19
    Sponsors: Scripps Translational Science Institute; Cue Health
    Recruiting

73. Chronic Stress as a Risk Factor for Long COVID

    2022-12-15 05:00:00 UTC

    Conditions: Long COVID; Acute COVID-19
    Sponsors: Medical University of Graz; University of Klagenfurt; Wayne State University
    Active, not recruiting

74. Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study: Study Understanding Pre-Exposure pRophylaxis of NOVel Antibodies (SUPERNOVA) Sub-study

    2022-12-13 05:00:00 UTC

    Conditions: COVID-19, SARS-CoV-2
    Interventions: Biological: AZD5156 (Parent study Sentinel Safety Cohort); Biological: Placebo (Parent study Sentinel Safety Cohort); Biological: EVUSHELD™ (Parent study Main Cohort); Biological: AZD3152 (Parent study Main Cohort); Biological: Placebo (Parent study Main Cohort); Biological: AZD3152 (Sub-study); Biological: AZD7442 - EVUSHELD™ (Sub-study); Biological: AZD7442 (EVUSHELD™) (Sub-study) Immunocompromised participants offered AZD3152
    Sponsors: AstraZeneca
    Active, not recruiting

75. Efficacy and Safety of Tozorakimab in Patients Hospitalised for Viral Lung Infection Requiring Supplemental Oxygen

    2022-11-22 05:00:00 UTC

    Conditions: Viral Lung Infection and Acute Respiratory Failure
    Interventions: Drug: Tozorakimab; Drug: Placebo
    Sponsors: AstraZeneca
    Recruiting

76. Understanding Patterns of Fatigue in Health and Disease

    2022-11-18 05:00:00 UTC

    Conditions: Myeloma; Long COVID; Heart Failure
    Interventions: Other: Observational
    Sponsors: University of Aberdeen; University of Cambridge; University of Glasgow; Lancaster University; University of Southampton; University College, London
    Active, not recruiting

77. Immunogenicity and Safety of ChulaCov19 BNA159 and ChulaCov19 BNA159.2 Vaccines as a Booster Dose in Adults

    2022-11-04 04:00:00 UTC

    Conditions: COVID-19, SARS CoV 2 Infection
    Interventions: Biological: ChulaCov19 BNA159 vaccine (50 mcg); Biological: Pfizer/BNT vaccine (30 mcg); Biological: COMVIGEN (ChulaCov19 BNA159.2) vaccine (50 mcg)
    Sponsors: Technovalia, Pty Ltd; Chulalongkorn University; BioNet-Asia; Southern Star Research Pty Ltd.
    Active, not recruiting

78. Strategies and Treatments for Respiratory Infections & Viral Emergencies (STRIVE): Shionogi Protease Inhibitor (Ensitrelvir)

    2022-11-04 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: Shionogi Protease Inhibitor (S-217622); Drug: placebo
    Sponsors: University of Minnesota; National Institute of Allergy and Infectious Diseases (NIAID)
    Recruiting

79. Immunogenicity of COVID-19 Vaccination in Autologous HSCT or CAR-T Cells Recipients

    2022-10-28 04:00:00 UTC

    Conditions: COVID-19; Non Hodgkin Lymphoma; Hodgkin Lymphoma, Adult
    Sponsors: Oliver Cornely, MD; ZKS Köln; German Federal Ministry of Education and Research
    Recruiting

80. Research on Community Based ATK Test Study to Control Spread of COVID-19 in Migrant Community

    2022-09-28 04:00:00 UTC

    Conditions: COVID-19 Pandemic
    Interventions: Device: STANDARD Q COVID-19 Ag Test
    Sponsors: University of Oxford
    Completed

81. Booster Study of SpikoGen COVID-19 Vaccine

    2022-09-16 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Biological: SpikoGen vaccine
    Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute Ltd; Cinnagen
    Active, not recruiting

82. COVID Booster in Pregnancy and Lactation

    2022-09-16 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Drug: Bivalent COVID-19 Booster
    Sponsors: Thomas Jefferson University; Walter Reed Army Institute of Research (WRAIR); Nemours Childrens Health
    Recruiting

83. Efficacy and Safety of Trimodulin (BT588) in Subjects With CAP Including COVID-19 Pneumonia

    2022-09-07 04:00:00 UTC

    Conditions: Respiratory Infection; Pneumonia; Community-acquired Pneumonia; Acute Respiratory Distress Syndrome; COVID-19; Viral Pneumonia; Bacterial Pneumonia; Fungal Pneumonia
    Interventions: Drug: Trimodulin; Drug: Placebo (human albumin 1%)
    Sponsors: Biotest
    Recruiting

84. COVID Protection After Transplant - Sanofi GSK (CPAT-SG) Study

    2022-08-26 04:00:00 UTC

    Conditions: COVID-19; Kidney Transplant
    Interventions: Biological: Sanofi-GSK monovalent (B.1.351) CoV2 preS dTM-AS03 COVID-19 vaccine
    Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); PPD; Johns Hopkins University; Sanofi Pasteur, a Sanofi Company
    Active, not recruiting

85. rSIFN-co Among Healthy Subjects and Subjects With Mild or Asymptomatic COVID-19

    2022-08-03 04:00:00 UTC

    Conditions: COVID-19; SARS-CoV-2 Infection
    Interventions: Drug: rSIFN-co Nasal Spray; Drug: rSIFN-co Nasal Spray; Drug: Placebo Nasal Spray; Drug: Placebo Nasal Spray
    Sponsors: Sichuan Huiyang Life Science and Technology Corporation
    Active, not recruiting

86. Genomics, Environmental Factors and Social Determinants of Cardiovascular Disease in African-Americans Study (GENE-FORECAST): Prospective COVID-19 Natural History Study

    2022-08-02 04:00:00 UTC

    Conditions: Heart Disease
    Sponsors: National Human Genome Research Institute (NHGRI)
    Completed

87. A Study to Learn About New COVID-19 RNA Vaccine Candidates in COVID-19 Vaccine-Experienced Healthy Individuals

    2022-07-25 04:00:00 UTC

    Conditions: SARS-CoV-2 Infection; COVID-19
    Interventions: Biological: BNT162b5 Bivalent (WT/OMI BA.2); Biological: BNT162b2 Bivalent (WT/OMI BA.1); Biological: BNT162b2 Bivalent (WT/OMI BA.4/BA.5); Biological: BNT162b5 Bivalent (Original/OMI BA.4/BA.5); Biological: BNT162b6 Bivalent (Original/OMI BA.4/BA.5); Biological: BNT162b7 Bivalent (Original/OMI BA.4/BA.5); Biological: BNT162b7 Monovalent (OMI BA.4/BA.5)
    Sponsors: BioNTech SE; Pfizer
    Completed

88. Passive Antibodies Against COVID-19 With EVUSHELD in Vaccine Non-responsive CLL

    2022-07-20 04:00:00 UTC

    Conditions: Chronic Lymphocytic Leukemia; COVID-19
    Interventions: Biological: EVUSHELD
    Sponsors: Sunnybrook Health Sciences Centre; AstraZeneca
    Withdrawn

89. A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

    2022-06-29 04:00:00 UTC

    Conditions: SARS-CoV-2
    Interventions: Biological: mRNA-1273.214; Biological: mRNA-1273.815
    Sponsors: ModernaTX, Inc.
    Recruiting

90. Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D Level

    2022-06-01 04:00:00 UTC

    Conditions: Acne Vulgaris; Vitamin D Deficiency; COVID-19
    Interventions: Diagnostic Test: Blood test and skin evaluation
    Sponsors: National Taiwan University Hospital
    Completed

91. COVID-19 Experiences in the SELF Cohort

    2022-05-11 04:00:00 UTC

    Conditions: COVID-19
    Sponsors: National Institute of Environmental Health Sciences (NIEHS)
    Enrolling by invitation

92. Immunotherapy for Neurological Post-Acute Sequelae of SARS-CoV-2

    2022-04-28 04:00:00 UTC

    Conditions: Systemic Inflammation; Neuroinflammation; Microvascular Thrombosis
    Interventions: Drug: IV normal saline; Drug: IV immunoglobulin
    Sponsors: National Institute of Neurological Disorders and Stroke (NINDS)
    Enrolling by invitation

93. Barriers and Facilitators of Key Stakeholders to Implement Remote Monitoring Technologies: a Mixed-methods Analysis

    2022-04-11 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Other: Semi-structured interviews will be conducted - there will be no intervention.
    Sponsors: Imperial College London
    Completed

94. A Study to Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

    2022-04-04 04:00:00 UTC

    Conditions: COVID-19; SARS-CoV-2 Infection
    Interventions: Biological: SCTV01E; Biological: Placebo
    Sponsors: Sinocelltech Ltd.
    Active, not recruiting

95. A Study to Learn About The COVID-19 (Study) Vaccine (Called COMIRNATY) in People That Are Less Than 21 Years Old.

    2022-03-25 04:00:00 UTC

    Conditions: Myocarditis
    Interventions: Diagnostic Test: Cardiac Imaging
    Sponsors: Pfizer; Carelon Research; National Heart, Lung, and Blood Institute (NHLBI)
    Recruiting

96. LatInamerican Vaccine Effectiveness Against Hospitalizations Due to Circulating COVID-19 VoC RWE Study

    2022-03-16 04:00:00 UTC

    Conditions: COVID-19, SARS-CoV-2
    Sponsors: AstraZeneca
    Completed

97. A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

    2022-03-15 04:00:00 UTC

    Conditions: COVID-19
    Interventions: Biological: Advax-CpG55.2 adjuvanted recombinant spike protein
    Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute
    Active, not recruiting

98. Covid-19 Vaccine Immune Response in Multiple Sclerosis

    2022-03-08 05:00:00 UTC

    Conditions: Multiple Sclerosis
    Interventions: Other: Blood Test 1; Other: Blood Test 2
    Sponsors: University Hospitals of North Midlands NHS Trust
    Active, not recruiting

99. Health System Methods to Improve Nursing Retention Amidst Ongoing COVID-19 Pandemic: a Mixed Method Study

    2022-03-07 05:00:00 UTC

    Conditions: Motivational Factors for Nurse Retention; Nurse Well-being
    Sponsors: Poudre Valley Health System
    Enrolling by invitation

100. Reparixin add-on Therapy to Std Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia

     2022-02-24 05:00:00 UTC

     Conditions: Infectious Pneumonia; Severe COVID-19
     Interventions: Drug: Reparixin; Other: Placebo
     Sponsors: Dompé Farmaceutici S.p.A
     Recruiting

101. COVID-19 & Psychiatry: A Retrospective Chart Review

     2022-02-17 05:00:00 UTC

     Conditions: COVID-19
     Interventions: Other: No intervention
     Sponsors: Northwestern University
     Active, not recruiting

102. Efficacy of Gabapentin for Post-Covid-19 Olfactory Dysfunction

     2022-01-11 05:00:00 UTC

     Conditions: COVID-19; Olfactory Disorder; Anosmia; Hyposmia; Parosmia
     Interventions: Drug: Gabapentin gelatin capsules 300mg; Drug: Placebo
     Sponsors: Washington University School of Medicine
     Completed

103. The Canadian Respiratory Research Network Long COVID-19 Study

     2022-01-06 05:00:00 UTC

     Conditions: SARS-CoV-2 Infection; Post-acute Sequelae of SARS-CoV-2
     Sponsors: Sunnybrook Health Sciences Centre; Canadian Institutes of Health Research (CIHR)
     Enrolling by invitation

104. Safety of Pediatric COVID-19 Vaccination

     2021-12-14 05:00:00 UTC

     Conditions: Pain; Injection Site Reaction; Adverse Drug Event
     Interventions: Other: Observational
     Sponsors: Duke University; Centers for Disease Control and Prevention; Kaiser Permanente; Columbia University; Children's Hospital Medical Center, Cincinnati
     Completed

105. Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

     2021-12-08 05:00:00 UTC

     Conditions: COVID-19
     Interventions: Biological: Spikogen/Covax-19
     Sponsors: Vaxine Pty Ltd; Australian Respiratory and Sleep Medicine Institute; Cinnagen
     Active, not recruiting

106. Randomized Double-Blind Phase 2 Study of Allogeneic HB-adMSCs for the Treatment of Chronic Post-COVID-19 Syndrome

     2021-11-19 05:00:00 UTC

     Conditions: Post COVID-19 Syndrome
     Interventions: Biological: HB-adMSCs (allogeneic); Other: Placebo
     Sponsors: Hope Biosciences Stem Cell Research Foundation
     Completed

107. Influence of the COVID-19 Pandemic on Dutch Surgical Patterns of Care

     2021-11-19 05:00:00 UTC

     Conditions: COVID-19
     Interventions: Other: no intervention
     Sponsors: University Medical Center Groningen
     Completed

108. Patients' Attitudes Toward and Experiences With Buprenorphine Treatment

     2021-11-16 05:00:00 UTC

     Conditions: Opioid-use Disorder; Acceptability of Health Care; Opioid-Related Disorders
     Sponsors: Cambridge Health Alliance; National Cancer Institute (NCI); National Center for Complementary and Integrative Health (NCCIH)
     Recruiting

109. COVID-19 (Coronavirus Disease-2019) Psychiatric Outcomes

     2021-11-15 05:00:00 UTC

     Conditions: Covid19; Anxiety; Mood; Cognitive Impairment
     Sponsors: Weill Medical College of Cornell University
     Terminated

110. Spike-specific Cellular Immune Response After COVID-19 Vaccination

     2021-11-01 04:00:00 UTC

     Conditions: COVID19; Vaccination; Immune Response
     Interventions: Other: analysis of immunological response; Diagnostic Test: analysis of serum antibodies
     Sponsors: IRCCS San Raffaele Roma
     Completed

111. Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic

     2021-11-01 04:00:00 UTC

     Conditions: COVID-19 Infection; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
     Interventions: Other: Best Practice; Procedure: Discussion; Other: Questionnaire Administration
     Sponsors: M.D. Anderson Cancer Center
     Active, not recruiting

112. Covid-19 Respiratory Sequelae French Cohort

     2021-10-13 04:00:00 UTC

     Conditions: COVID-19; Fibrosis; Cohort; Follow-up; Sequelae; Spirometry DLCO
     Sponsors: Centre Hospitalier Universitaire, Amiens; Cabinet Medical valenciennes; CH Aix; hopital privé de bois bernard; Clinique La Croix du Sud; University Hospital, Bordeaux; Hopital Forcilles; Hopital d'instructions des armées; Hôpital Européen Marseille; Rennes University Hospital; Clinique Saint Augustin; Delafontaine Hospital; Centre Hospitalier Universitaire de Saint Etienne; Centre Hospitalier de Troyes; Centre Hospitalier le Mans; University Hospital, Clermont-Ferrand; University Hospital, Tours
     Active, not recruiting

113. A Study of Baricitinib (LY3009104) in Children With COVID-19

     2021-10-12 04:00:00 UTC

     Conditions: Covid19; Corona Virus Infection
     Interventions: Drug: Baricitinib
     Sponsors: Eli Lilly and Company
     Recruiting

114. A Phase 1/2 Study to Determine Safety and Immunogenicity of Two COVID 19 Vaccines VB10.2129 (RBD Candidate) and VB10.2210 (T Cell Candidate) Previously Vaccinated in Healthy Adult Volunteers

     2021-10-06 04:00:00 UTC

     Conditions: COVID-19; Infection Viral; Infections
     Interventions: Biological: VB10.2129; Biological: VB10.2210
     Sponsors: Nykode Therapeutics ASA; Vaccibody AS
     Completed

115. "Efesovir" (FS-1) for COVID-19, Phase 2

     2021-09-29 04:00:00 UTC

     Conditions: Covid19
     Interventions: Drug: Efesovir
     Sponsors: Scientific Center for Anti-infectious Drugs, Kazakhstan
     Not yet recruiting

116. COVID-19: Infectious Potential of SARS-CoV-2 Intestinal Shedding in Pediatric Patients (INPOSIS)

     2021-09-24 04:00:00 UTC

     Conditions: SARS-CoV-2 Infection; Covid19; Intestinal Infection
     Sponsors: St. Anna Kinderkrebsforschung
     Completed

117. Korea Comirnaty Post-marketing Surveillance

     2021-09-02 04:00:00 UTC

     Conditions: COVID-19; Vaccines; Adverse Effects; SARS-CoV-2; Safety
     Interventions: Biological: Tozinameran 12 Years of age and older; Biological: Tozinameran 5 to 11 Years of age; Biological: Tozinameran 6 months to 4 years of age; Biological: Riltozinameran 12 Years of age and older; Biological: Famtozinameran 12 Years of age and older; Biological: Famtozinameran 5 to 11 Years of age; Biological: Raxtozinameran 12 years of age and older; Biological: Raxtozinameran 6 months to 4 years of age
     Sponsors: Pfizer
     Active, not recruiting

118. Evaluation of Serial Ultrasound Screening in ICU COVID-19 Patients

     2021-08-31 04:00:00 UTC

     Conditions: Deep Vein Thrombosis; Covid19; COVID-19 Pneumonia; COVID-19 Respiratory Infection; COVID-19 Acute Respiratory Distress Syndrome; COVID-19 Acute Bronchitis; COVID-19 Lower Respiratory Infection; Pulmonary Embolism
     Interventions: Diagnostic Test: venous ultrasound of lower extremity
     Sponsors: Hospital Universitari Vall d'Hebron Research Institute; Universitat Autonoma de Barcelona
     Completed

119. Lung Structure-Function In SurVivors of Mild and SEvere COVID-19 Infection: 129Xe MRI

     2021-08-20 04:00:00 UTC

     Conditions: COVID-19 Respiratory Infection
     Interventions: Drug: 129Xenon gas
     Sponsors: The Hospital for Sick Children; Western University
     Terminated

120. Immunogenicity and Safety Study of SK SARS-CoV-2 Recombinant Nanoparticle Vaccine (GBP510) Adjuvanted With AS03 (COVID-19)

     2021-08-17 04:00:00 UTC

     Conditions: Covid19
     Interventions: Biological: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose); Biological: ChAdOx1-S not less than 2.5 × 10^8 infectious units; Biological: GBP510 adjuvanted with AS03 (Receptor-Binding Domain(RBD) 25ug/dose)
     Sponsors: SK Bioscience Co., Ltd.; International Vaccine Institute; GlaxoSmithKline; Coalition for Epidemic Preparedness Innovations
     Completed

121. COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders

     2021-08-11 04:00:00 UTC

     Conditions: Rheumatoid Arthritis (RA); Systemic Lupus Erythematosus (SLE); Pemphigus Vulgaris; Multiple Sclerosis (MS); Systemic Sclerosis (SSc); Pediatric SLE; Juvenile Idiopathic Arthritis (JIA); Juvenile Dermatomyositis (JDM); Pediatric-Onset Multiple Sclerosis (POMS)
     Interventions: Biological: Moderna mRNA-1273; Biological: BNT162b2; Biological: Ad26.COV2.S; Drug: Continue IS (MMF or MPA); Drug: Continue IS (MTX); Biological: Continue IS (B cell depletion therapy); Biological: Monovalent [B.1.351] CoV2 preS dTM-AS03; Drug: Withhold IS (MMF or MPA); Drug: Withhold IS (MTX); Drug: Withhold IS (B cell depletion therapy); Biological: Moderna mRNA-1273, Bivalent; Biological: BNT162b2, Bivalent
     Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Autoimmunity Centers of Excellence; Rho Federal Systems Division, Inc.
     Completed

122. Study of Allogeneic Adipose-Derived Mesenchymal Stem Cells to Treat Post COVID-19 "Long Haul" Pulmonary Compromise

     2021-08-05 04:00:00 UTC

     Conditions: Covid19
     Interventions: Biological: COVI-MSC; Biological: Placebo
     Sponsors: Sorrento Therapeutics, Inc.
     Withdrawn

123. Post COVID-19 Interstitial Lung Disease: A Study of Genetic and Environmental Interactions

     2021-08-03 04:00:00 UTC

     Conditions: Pulmonary Fibrosis; COVID-19 Pneumonia
     Sponsors: Imperial College London
     Completed

124. Women s Health Awareness Community Resiliency, Environmental Action and Collaborations for Health (REACH) Equity

     2021-07-30 04:00:00 UTC

     Conditions: Mental Health
     Sponsors: National Institute of Environmental Health Sciences (NIEHS)
     Recruiting

125. Baricitinib in Hospitalized Covid-19 Patients With Diabetes Mellitus

     2021-07-21 04:00:00 UTC

     Conditions: COVID-19 Pneumonia
     Interventions: Drug: Baricitinib; Drug: Dexamethasone; Drug: Remdesivir
     Sponsors: Bangladesh Institute of Research and Rehabilitation in Diabetes, Endocrine and Metabolic Disorders
     Withdrawn

126. COVID-19 Recovery Study: Symptoms and Biomarkers of Long COVID-19 in People Living With and Without HIV

     2021-07-12 04:00:00 UTC

     Conditions: Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV2); HIV
     Interventions: Other: No intervention
     Sponsors: Johns Hopkins University; Rush University Medical Center; University of California, San Francisco; amfAR, The Foundation for AIDS Research
     Completed

127. Caregiving During Crisis

     2021-06-25 04:00:00 UTC

     Conditions: Caregiver Stress Syndrome
     Interventions: Behavioral: Psychoeducational Intervention
     Sponsors: Emory University; National Institute on Aging (NIA)
     Completed

128. Benefit of Expanded Surveillance of Nursing Homes During the COVID-19 Pandemic

     2021-06-22 04:00:00 UTC

     Conditions: COVID-19 Respiratory Infection; SARS-CoV-2 Infection
     Interventions: Diagnostic Test: Nasopharyngeal swab for SARS-CoV-2
     Sponsors: University of Cologne; City Council of Cologne, Department of Public Health, NRW, Germany; City Council of Cologne, Department of Social Affairs, Health and Environment, NRW, Germany
     Completed

129. InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic pAtients With COVID-19 Infection (Brazil Cohort)

     2021-06-15 04:00:00 UTC

     Conditions: COVID-19; Lymphocytopenia
     Interventions: Drug: Interleukin-7; Drug: PLACEBO
     Sponsors: Revimmune; C.R.O. ReSolution Latin America S.A.
     Terminated

130. Allogeneic Natural Killer (NK) Cell Therapy in Subjects Hospitalized for COVID-19

     2021-05-25 04:00:00 UTC

     Conditions: COVID-19 Pneumonia
     Interventions: Biological: DVX201
     Sponsors: Coeptis Therapeutics; Fred Hutchinson Cancer Center
     Completed

131. The Impact of the COVID-19 Pandemic on Eating Behavior and Weight Change

     2021-05-21 04:00:00 UTC

     Conditions: COVID-19; Obesity
     Sponsors: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
     Active, not recruiting

132. Yale COVID-19 Recovery Study

     2021-05-20 04:00:00 UTC

     Conditions: Covid19 Sequelae
     Interventions: Other: No intervention
     Sponsors: Yale University; Food and Drug Administration (FDA)
     Active, not recruiting

133. COVID-19 and Psycological Well-being in Healthcare Workers

     2021-05-18 04:00:00 UTC

     Conditions: Distress, Emotional; Coping Behavior
     Interventions: Behavioral: well-being assessment
     Sponsors: IRCCS San Raffaele Roma
     Completed

134. Implementation and Evaluation of a Stepped-Care Mental Health Treatment Program for Patients With Chronic Pain

     2021-05-13 04:00:00 UTC

     Conditions: Chronic Pain
     Interventions: Other: Stepped-Care Model
     Sponsors: University Health Network, Toronto
     Active, not recruiting

135. Study of Sputnik V COVID-19 Vaccination in Adults in Kazakhstan

     2021-05-04 04:00:00 UTC

     Conditions: Covid19; Vaccine Adverse Reaction
     Interventions: Biological: Sputnik V
     Sponsors: Karaganda Medical University; McMaster University
     Completed

136. Immune Response in Dialysis Patients Vaccinated Against COVID-19

     2021-03-18 04:00:00 UTC

     Conditions: Covid19; Chronic Kidney Disease 5D
     Sponsors: Saint Petersburg State University, Russia
     Completed

137. Myocardial Injury and Quality of Life After COVID-19

     2021-03-11 05:00:00 UTC

     Conditions: COVID-19; Myocardial Injury; Myocarditis Post Infection
     Sponsors: Voronezh Regional Clinical Consultative and Diagnostic Center; Voronezh State Medical University named after N.N. Burdenko; Charles University, Czech Republic
     Completed

138. Long COVID Kids DK - Investigating Long-term Covid-19

     2021-03-08 05:00:00 UTC

     Conditions: Covid-19
     Interventions: Other: LongCOVIDkidsDK
     Sponsors: Rigshospitalet, Denmark
     Active, not recruiting

139. Vaccine Observation to Include All Communities for Equitable Science

     2021-02-25 05:00:00 UTC

     Conditions: Vaccine Response Impaired; Vaccine Adverse Reaction
     Interventions: Biological: COVID-19 vaccine
     Sponsors: Persephone Biosciences
     Terminated

140. National Cohort Study of Effectiveness and Safety of SARS-CoV-2/COVID-19 Vaccines (ENFORCE)

     2021-02-18 05:00:00 UTC

     Conditions: SARS-CoV Infection
     Interventions: Biological: COMIRNATY - BioNTech Manufacturing GmbH; Biological: COVID-19 Vaccine Moderna dispersion for injection - MODERNA BIOTECH; Biological: COVID-19 Vaccine AstraZeneca suspension for injection
     Sponsors: Jens D Lundgren, MD; Ministry of the Interior and Health, Denmark
     Completed

141. Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2) Immune Kidney Transplant Study (COVID-19)

     2021-02-10 05:00:00 UTC

     Conditions: Kidney Transplant Infection; SARS-CoV Infection
     Interventions: Drug: SARS-CoV-2 vaccine
     Sponsors: Oslo University Hospital
     Active, not recruiting

142. Institut de Recherche Cliniques de Montreal (IRCM) Post-COVID-19 (IPCO) Research Clinic

     2021-02-03 05:00:00 UTC

     Conditions: Covid19
     Interventions: Other: Medical follow-up
     Sponsors: Emilia Falcone, MD
     Recruiting

143. Understanding Exertional Dyspnea and Exercise Intolerance in COVID-19

     2021-02-01 05:00:00 UTC

     Conditions: Covid19; Dyspnea
     Interventions: Other: No Intervention
     Sponsors: University of Alberta
     Active, not recruiting

144. Mental and Physical Well-Being of Frontline Health Care Workers During Coronavirus Disease 2019 (COVID-19)

     2021-01-25 05:00:00 UTC

     Conditions: Healthy
     Interventions: Behavioral: Stress First Aid
     Sponsors: RAND; Stanford University; Clinical Directors Network; Vizient
     Completed

145. Anti-COVID19 AKS-452 Fusion Protein Vaccine - ACT Study

     2020-12-23 05:00:00 UTC

     Conditions: Covid19
     Interventions: Biological: AKS-452
     Sponsors: University Medical Center Groningen; Akston Biosciences Corporation
     Completed

146. Double Blind, Placebo Controlled Study of Safety and Efficacy of Leronlimab in Patients With "Long" COVID-19

     2020-12-22 05:00:00 UTC

     Conditions: Coronavirus Disease 2019
     Interventions: Drug: Placebos; Drug: Leronlimab (700mg)
     Sponsors: CytoDyn, Inc.; Amarex Clinical Research
     Completed

147. SARS-CoV-2 Donor-Recipient Immunity Transfer

     2020-12-14 05:00:00 UTC

     Conditions: Accelerated Phase CML, BCR-ABL1 Positive; Acute Lymphoblastic Leukemia; Acute Myeloid Leukemia; Chronic Lymphocytic Leukemia; Chronic Phase CML, BCR-ABL1 Positive; COVID-19 Infection; Hematopoietic and Lymphoid Cell Neoplasm; Hodgkin Lymphoma; Lymphoblastic Lymphoma; Myelodysplastic Syndrome; Myelofibrosis; Myeloproliferative Neoplasm; Non-Hodgkin Lymphoma
     Interventions: Procedure: Biospecimen Collection; Other: Diagnostic Laboratory Biomarker Analysis; Other: Electronic Health Record Review; Other: Questionnaire Administration
     Sponsors: City of Hope Medical Center; National Cancer Institute (NCI)
     Completed

148. A Study of FOY-305 in Patients With SARS-Cov-2 Infection (COVID-19)

     2020-12-08 05:00:00 UTC

     Conditions: SARS-CoV-2 Infection (COVID-19)
     Interventions: Drug: FOY-305; Drug: Placebo
     Sponsors: Ono Pharmaceutical Co. Ltd
     Completed

149. SARS-CoV-2-Neutralizing Monoclonal COVID-19 Antibody DZIF-10c by Infusion

     2020-11-17 05:00:00 UTC

     Conditions: SARS-CoV-2 Infection
     Interventions: Biological: DZIF-10c; Other: Placebo
     Sponsors: University of Cologne; ZKS Köln; Boehringer Ingelheim
     Completed

150. The Study of the Use of Nintedanib in Slowing Lung Disease in Patients With Fibrotic or Non-Fibrotic Interstitial Lung Disease Related to COVID-19

     2020-11-06 05:00:00 UTC

     Conditions: Pulmonary Fibrosis; Interstitial Lung Disease; Respiratory Disease
     Interventions: Drug: Nintedanib; Drug: Placebo
     Sponsors: Icahn School of Medicine at Mount Sinai; Boehringer Ingelheim
     Completed

151. SARS-COV2 Pandemic Serosurvey in a Rare Disease Population

     2020-10-30 04:00:00 UTC

     Conditions: SARS-COV2 Virus
     Sponsors: National Institute of Allergy and Infectious Diseases (NIAID)
     Completed

152. Remotely Delivered Programs Targeting COVID-19 Stress-Related Depression and Substance Use

     2020-10-20 04:00:00 UTC

     Conditions: Depression; Anxiety; Substance Use; Stress, Psychological; Stress, Emotional; Alcohol Use, Unspecified; Drug Use; Covid19
     Interventions: Behavioral: Mindfulness Based Cognitive Therapy for Resilience During COVID-19 plus CHAMindWell; Behavioral: Internet Cognitive Behavioral Therapy plus CHAMindWell; Behavioral: CHAMindWell
     Sponsors: Cambridge Health Alliance; National Center for Complementary and Integrative Health (NCCIH); Penn State University
     Completed

153. COVID-19 Serology and Immunosenescence

     2020-09-24 04:00:00 UTC

     Conditions: Covid19; Geriatric Medicine; Seroconversion; Immunosenescence
     Interventions: Biological: blood sample
     Sponsors: Centre Hospitalier Universitaire, Amiens
     Active, not recruiting

154. Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

     2020-09-10 04:00:00 UTC

     Conditions: Coronavirus Disease 2019 (COVID-19)
     Interventions: Biological: COVID-19 convalescent plasma
     Sponsors: VA Office of Research and Development; Mayo Clinic
     Completed

155. COVID-19 in a Single Large UK Rheumatology Centre and Impact on QOL

     2020-09-09 04:00:00 UTC

     Conditions: Covid19; Rheumatic Diseases
     Interventions: Other: Questionnaire
     Sponsors: The Royal Wolverhampton Hospitals NHS Trust
     Completed

156. COVID-FIS: Pilot in COVID-19 (SARS-CoV-2) of Fisetin in Older Adults in Nursing Homes

     2020-09-03 04:00:00 UTC

     Conditions: Covid19; SARS-CoV Infection
     Interventions: Drug: Fisetin; Drug: Placebo
     Sponsors: Mayo Clinic; National Institute on Aging (NIA)
     Active, not recruiting

157. Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 ACUTE

     2020-08-10 04:00:00 UTC

     Conditions: Covid19
     Interventions: Drug: theraputic heparin; Drug: prophylactic heparin; Drug: P2Y12; Drug: Crizanlizumab Injection; Drug: SGLT2 inhibitor
     Sponsors: Matthew Neal MD; National Heart, Lung, and Blood Institute (NHLBI)
     Active, not recruiting

158. Well-Being and Health-Related Quality of Life in Cancer Patients and Survivors During the COVID-19 Pandemic

     2020-08-05 04:00:00 UTC

     Conditions: COVID-19 Infection; Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
     Interventions: Other: Quality-of-Life Assessment; Other: Questionnaire Administration
     Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
     Recruiting

159. Umbilical Cord Lining Stem Cells (ULSC) in Patients With COVID-19 ARDS

     2020-07-31 04:00:00 UTC

     Conditions: Covid19; Corona Virus Infection; SARS-CoV Infection; ARDS; Coronavirus
     Interventions: Biological: Umbilical Cord Lining Stem Cells (ULSC); Other: Placebo (carrier control)
     Sponsors: Restem, LLC.
     Completed

160. Serological Surveillance for COVID-19 in Central North Carolina

     2020-07-29 04:00:00 UTC

     Conditions: COVID-19
     Sponsors: National Institute of Environmental Health Sciences (NIEHS)
     Completed

161. Breathing Techniques and Meditation for Health Care Workers During COVID-19 Pandemic

     2020-07-22 04:00:00 UTC

     Conditions: COVID-19 Infection
     Interventions: Other: Media Intervention; Procedure: Meditation Therapy; Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Procedure: Yoga
     Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
     Active, not recruiting

162. Online Delivery of Psychotherapy, Tailored to Patients' Suffering From Mental Health Problems Due to COVID-19

     2020-07-20 04:00:00 UTC

     Conditions: Mental Health Issue; Covid19; Anxiety Disorders; Depression
     Interventions: Behavioral: e-Psychotherapy
     Sponsors: Dr. Nazanin Alavi; Online PsychoTherapy Clinic
     Completed

163. Optimising Resource Allocation Via Prediction of Outcomes for Covid-19

     2020-07-16 04:00:00 UTC

     Conditions: COVID19
     Sponsors: Nottingham University Hospitals NHS Trust; East Midlands Academic Health Sciences Network
     Completed

164. COPE - COVID-19 in Pregnancy and Early Childhood

     2020-06-16 04:00:00 UTC

     Conditions: Sars-CoV2; Covid-19; Pregnancy Complications; Pregnancy Preterm; Pregnancy in Diabetic; Neonatal Infection
     Interventions: Other: biological samples, questionnaires and interviews
     Sponsors: Sahlgrenska University Hospital, Sweden
     Active, not recruiting

165. Remote Continues Glucose Monitoring During the COVID-19 Pandemic in Quarantined Hospitalized Patients

     2020-06-12 04:00:00 UTC

     Conditions: Diabetes; Covid-19; Infection
     Interventions: Device: Dexcom G6
     Sponsors: Nordsjaellands Hospital
     Completed

166. InterLeukin-7 to Improve Clinical Outcomes in Lymphopenic Patients With COVID-19 Infection ( ILIAD-7-US-O )

     2020-06-11 04:00:00 UTC

     Conditions: COVID-19; Lymphocytopenia
     Interventions: Drug: CYT107; Drug: Placebo
     Sponsors: Revimmune; Memorial Sloan Kettering Cancer Center; Amarex Clinical Research; M.D. Anderson Cancer Center; Cancer Research Institute, New York City
     Terminated

167. A Study of LY3819253 (LY-CoV555) and LY3832479 (LY-CoV016) in Participants With Mild to Moderate COVID-19 Illness

     2020-06-11 04:00:00 UTC

     Conditions: COVID-19
     Interventions: Drug: LY3819253; Drug: LY3832479; Drug: LY3853113; Drug: Placebo
     Sponsors: Eli Lilly and Company; AbCellera Biologics Inc.; Shanghai Junshi Bioscience Co., Ltd.
     Completed

168. Serological Study of the Exposure of Personnel to COVID-19

     2020-06-09 04:00:00 UTC

     Conditions: Sars-CoV2
     Interventions: Diagnostic Test: Sars-Cov-2 serology
     Sponsors: Centre Hospitalier Saint Joseph Saint Luc de Lyon
     Completed

169. Effect of Lactobacillus on the Microbiome of Household Contacts Exposed to COVID-19

     2020-05-22 04:00:00 UTC

     Conditions: Microbiome
     Interventions: Dietary Supplement: Lactobacillus rhamnosus GG; Dietary Supplement: Lactobacillus rhamnosus GG Placebo
     Sponsors: Duke University
     Completed

170. NCI COVID-19 in Cancer Patients, NCCAPS Study

     2020-05-14 04:00:00 UTC

     Conditions: COVID-19 Infection; Hematopoietic and Lymphatic System Neoplasm; Malignant Solid Neoplasm; Metastatic Malignant Solid Neoplasm
     Interventions: Procedure: Biospecimen Collection; Other: Data Collection; Other: Quality-of-Life Assessment; Other: Questionnaire Administration
     Sponsors: National Cancer Institute (NCI)
     Active, not recruiting

171. COVID-19 Infection in Patients With Hepatocellular Carcinoma

     2020-04-29 04:00:00 UTC

     Conditions: Hepatocellular Carcinoma; COVID-19
     Interventions: Diagnostic Test: nasopharyngeal Covid 19 RT-PCR
     Sponsors: Centre Hospitalier Universitaire, Amiens; Centre Hospitalier-Universitaire Bondy; University Hospital, Bordeaux; Centre Hospitalier-Universitaire CLICHY; Centre Hospitalier Général CORBEIL-ESSONNE; CHU CRETEIL; University Hospital, Grenoble; University Hospital, Lille; CHU LYON; Poitiers University Hospital; Rennes University Hospital; University Hospital, Rouen; University Hospital, Toulouse; CHU VILLEJUIF; Central Hospital, Nancy, France; Centre Hospitalier Universitaire de Nice; University Hospital, Montpellier
     Active, not recruiting

172. St. Jude Tracking of Viral and Host Factors Associated With COVID-19

     2020-04-27 04:00:00 UTC

     Conditions: COVID-19; Coronavirus Infection; Coronavirus; SARS-CoV-2
     Sponsors: St. Jude Children's Research Hospital; University of Georgia; University of Wisconsin, Madison; National Institute of Allergy and Infectious Diseases (NIAID)
     Active, not recruiting

173. Chronic Fatigue Etiology and Recovery in Covid-19 Patients: the Role of Fatigability

     2020-04-27 04:00:00 UTC

     Conditions: Chronic Fatigue Syndrome; Intensive Care Unit; Muscle
     Interventions: Other: Questionnaires; Biological: blood test; Other: Maximal effort test; Device: actigraphy; Device: Neuromuscular evaluation; Other: stool analysis; Other: food diary
     Sponsors: Centre Hospitalier Universitaire de Saint Etienne; University of Saint-Etienne; Laboratoire des Adaptations Métaboliques à l'Exercice en conditions Physiologiques et Pathologiques
     Recruiting

174. Collection of Biological Samples With Clinical Characterization of Covid-19 Patients

     2020-04-27 04:00:00 UTC

     Conditions: Covid-19
     Interventions: Biological: Biological test
     Sponsors: Centre Hospitalier Intercommunal Creteil
     Terminated

175. Efficacy and Safety of Convalescent Plasma in Treating COVID-19 Hospitalized Patients

     2020-04-21 04:00:00 UTC

     Conditions: COVID-19
     Interventions: Biological: anti-SARS-CoV-2 convalescent plasma
     Sponsors: Medical College of Wisconsin; Froedtert Hospital
     Completed

176. SAFEty Study of Early Infusion of Vitamin C for Treatment of Novel Coronavirus Acute Lung Injury (SAFE EVICT CORONA-ALI)

     2020-04-14 04:00:00 UTC

     Conditions: COVID-19; Lung Injury, Acute; Kidney Injury
     Interventions: Drug: L-ascorbic acid; Other: Placebo
     Sponsors: Virginia Commonwealth University
     Completed

177. Sirolimus Treatment in Hospitalized Patients With COVID-19 Pneumonia

     2020-04-10 04:00:00 UTC

     Conditions: COVID-19
     Interventions: Drug: Sirolimus; Drug: Placebo
     Sponsors: University of Cincinnati
     Completed